---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "rHjL644y6Vp7JmE++TU8oSB3PbODdh2/HFyqf3Nv5t/L3Uv4is4vi5706jLgaJ3dqNBYFe2N1zXTP4yd6XJYhTd2hxusvObglMTRHvSndIdfSB6eh9c01UWL79/2E57FVAbmt4SUMxel1Si5OdTTe2OPEm83pax/GBVVJdPx4ZOPcCZjJlTsn5XpAofSG0d0GDCXQwUgXJ6X2LftbgfqeJee80Q6WAgaK3WQ/RiiuUD+lwnp/h5kxG2BL5m3nLxxRoZXBQXeGx4NebDEpvaotojzCcHvuETrEMWSYM9O9DT7b4/NtnQWpzqjWkKRsJrkC6oKa/K//xsdgnPrPR4ezL4n9g+5Q0ia83V1OGD19VE=;nibVAYLOCPdFukLa5iB6Rg=="
---

